EPIVAC Study Group
Biographic Data
| ID | 7747086 |
|---|---|
| NAME | EPIVAC Study Group |
| GIVEN NAMES | EPIVAC Study |
| FAMILY NAME | Group |
| SIGNATURE | GROUP E S |
| AFFILIATIONS | Institut Català de la Salut |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2017 |
| H-INDEX | 0 |
Prevalence of high, medium and low-risk medical conditions for pneumococcal vaccination in Catalonian middle-aged and older adults
In our setting, approximately 50 % of overall persons 50 years or older may be considered at-risk population for pneumococcal disease (almost 10 % have high-risk conditions and 40 % have other risk conditions)
Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years
Our data supports a benefit of PPV23 against ischaemic stroke among the general population over 60 years, suggesting a possible protective role of pneumococcal vaccination against some acute thrombotic events
No prominent works on this page.
Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years
Our data supports a benefit of PPV23 against ischaemic stroke among the general population over 60 years, suggesting a possible protective role of pneumococcal vaccination against some acute thrombotic events
Prevalence of high, medium and low-risk medical conditions for pneumococcal vaccination in Catalonian middle-aged and older adults
In our setting, approximately 50 % of overall persons 50 years or older may be considered at-risk population for pneumococcal disease (almost 10 % have high-risk conditions and 40 % have other risk conditions)
Environmental health (2 works) · Influenza Virus Research Studies (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Pediatrics (2 works) · Population (2 works) · Atherosclerosis and Cardiovascular Diseases (1 work) · Bacterial Infections and Vaccines (1 work) · Chronic liver disease (1 work) · Cohort (1 work)